Transcript of Conference call with Analysts / Investors on Financial Results for the quarter and half year ended 30th September, 2026

29th October, 2026 The Dy. General Manager (Listing Dept.) The Manager – Listing Dept., BSE Limited, National Stock Exchange of India Ltd., Corporate Relationship Dept., Exchange Plaza, 5th Floor, 1st Floor, New Trading Ring, Plot No. C/1, G. Block, P. J. Towers, Dalal Street, Fort, Bandra - Kurla Complex, Bandra (E), Mumbai - 400 001 Mumbai – 400 051 (BSE Scrip Code: 500420) (NSE Scrip Code: TORNTPHARM) Dear Sir, Sub.: Transcript of Conference call with Analysts / Investors on Financial Results for the quarter and half year ended 30th September, 2026 In continuation of our letter dated 09th October, 2026 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Transcript of Conference call with Analysts / Investors on Financial Results of the Company for the quarter and half year ended 30th September, 2026, has been placed on the Company’s website at https://torrentpharma.com/pdf/investors/Q2-FY26-27_Earnings-Call-Transcript.pdf Kindly take note of the above. Thanking you, Yours Sincerely, For TORRENT PHARMACEUTICALS LIMITED CHINTAN M. TRIVEDI COMPANY SECRETARY Email – investorservices@torrentpharma.com